Here's Why Insulet (PODD) is a Strong Growth Stock

Zacks Investment Research suggests Insulet (PODD), a developer of the Omnipod Insulin Management System, as a growth stock pick, citing a Growth Style Score of B and a projected 34.9% year-over-year earnings growth for the current fiscal year. The consensus earnings estimate for fiscal 2025 has increased by $0.08 to $4.37 per share, with six analysts revising estimates upward in the last 60 days; PODD currently holds a Zacks Rank #3 (Hold) with a VGM Score of B.

Analysis

Insulet Corporation (PODD), developer of the Omnipod Insulin Management System, currently holds a Zacks Rank #3 (Hold) but exhibits strong growth characteristics. The company has earned a VGM Score of B and a Growth Style Score of B, underpinned by a significant projected year-over-year earnings growth of 34.9% for the current fiscal year. This positive outlook is further supported by recent analyst activity; six analysts have revised their earnings estimates upward for fiscal 2025 within the last 60 days, contributing to an $0.08 increase in the Zacks Consensus Estimate to $4.37 per share. Moreover, Insulet has a track record of exceeding expectations, boasting an average earnings surprise of 12.2%. While the overall Zacks Rank suggests a neutral stance, the strong growth metrics and positive estimate revisions indicate underlying fundamental strength relevant for growth-focused investors.

Key Decisions for Investors

• Investors focused on growth should note PODD's projected 34.9% earnings growth and recent positive fiscal 2025 estimate revisions, which present a compelling case despite the current Zacks #3 (Hold) rating.
• The B-rated Growth and VGM Style Scores suggest underlying strength; therefore, consider placing PODD on a watchlist, as an improvement in its Zacks Rank could signal a more opportune entry point.
• Closely monitor Insulet's upcoming earnings announcements and any further analyst estimate revisions, as its history of a 12.2% average earnings surprise indicates potential for continued positive performance against expectations.